HIV, the virus that causes AIDS, is shown budding out of an immune cell, which the virus infects and uses to replicate.NIH, via Wikimedia Commons
For more than 20 years, powerful drug combinations of antiretroviral drugs have been available to treat people with HIV infection, and these agents have dramatically raised life expectancy for HIV-infected patients from 36 to 49 years of age.
Though combinatorial antiretroviral therapies (CART) reduces viral
loads to undetectable levels in the blood, HIV can hide within the
central nervous system, where it can integrate into the genomes of brain
cells called microglia – the immune cells of the brain.
In the brain, HIV continues to produce viral proteins and damage both
infected and non-infected cells in the brain, boosting the risk for
dementia, addiction and other neurological problems. Everyone with HIV
will experience this, since HIV integrates into the genome and CART has
issues crossing into the brain. The question is: why?
HIV proteins dysregulate dopamine signaling
To answer this, we used a mouse in which we can control the levels of
HIV viral protein in order to probe the link between HIV infection and
neurological disease.
Our lab discovered that an HIV protein, called HIV-1 Tat, reduces the
level of an important protein required for the production of a
dopamine, a neurotransmitter, in the brain.
Dopamine is produced by neurons in the central nervous system and by immune cells in the blood. Using a confocal microscope
to see fine details, my colleagues and I carefully examined the
dopamine producing areas in the brains of mice containing HIV-1 Tat
protein and were surprised to discover that the neurons were alive. But,
many that normally produced dopamine were unable to produce as much. We
also found that an enzyme necessary to make dopamine, called tyrosine
hydroxylase, was no longer detectable in some neurons. This suggests
that the mice can’t make as much dopamine.
When microglial cells secrete the HIV-1 Tat protein, it is able to
enter dopamine neurons and lower their activity so that they produce
less dopamine. That reduces their ability to communicate with other
cells in the brain, which can disrupt the ability to move and reward
related behaviors. Also, low levels of dopamine in an area of the brain
called the substantia nigra is a hallmark of Parkinson’s and
predisposes patients to depression and addiction to drugs like methamphetamine and cocaine.
The results of our research, published in the journal Glia,
reveal how HIV patients are more vulnerable to neurological and
neuropsychiatric conditions that are somehow tied to disrupting dopamine
levels in the brain.
There is clearly more to treating HIV that curbing levels of the
virus in the blood. The medical community needs treatments that reverse
the long-term consequences of HIV infection in the brain.
Enterotoxigenic Escherichia coli (ETEC) is known as a major cause of diarrhea in travelers and people living in developing countries. According to the World Health Organization (WHO), ETEC is responsible for 300,000 ~ 500,000 deaths a year, constituting a serious problem. Effective vaccines for ETEC have not been developed, so patients infected with ETEC are treated with antibiotics and supporting measures. However, the emergence of multidrug-resistant bacteria has become a social issue, so the development of new treatment methods is sought after. Adherence to the host intestinal epithelium is an essential step for ETEC infection in humans. It was thought that a filamentous structure on the surface of bacteria called 'type IV pilus' was important for bacterial attachment, but its detailed adhesion mechanism was not known. Osaka University-led researchers clarified how pathogenic E.coli attached to the host intestinal epithelium using type IV pili and secre...
As antibiotic resistance increases the search for new anti-bacterial treatments becomes more and more important. One way to design anti-bacterials is to find specific biochemical pathways that the bacteria require to survive, and develop drugs that block off these pathways. Some pathways are better targets than others and for Salmonella bacteria it was thought that pathways dealing with nutrient metabolises would be a lost cause. Salmonella lives in the intestine, which hosts a whole variety of different nutrients, so surely preventing the bacteria from using a specific one wouldn’t cause them much undue distress. It’s been found, however, that as they grow and spread in the inflamed intestine the bacteria are heavily reliant on one particular nutrient: fructose-asparagine. The chemical structure of fructose-asparagine, image from the reference. The importance of fructose-asparagine metabolism was originally discovered durin...
Even living cells have their own tangled problems to solve. They involve knots that arise accidentally in DNA and that can comprise its functionality. A new study by SISSA (Scuola Internazionale Superiore di Studi Avanzati) brings a new twist to the problem and suggests that the DNA propensity to be supercoiled, just like telephone cords, can come to the rescue. These coils can keep DNA knots locked in place for long enough that they can be untied by specialised enzymes. The computational study, based on molecular dynamics simulations of bacterial DNA, has just been published in Nucleic Acids Research . A tangled problem Supercoiled, twisted, and even knotted! Far from the elegant and polished textbook images, DNA filaments in living cells is all crumpled and entangled and, to be functional, needs to be constantly unravelled, much like our telephone cords that with careless use accumulate annoying curls or supercoils. "Supercoils are, in fact, present in DNA too ...
Comments
Post a Comment